finasteride sold brand names proscar propecia among others medication used treat pattern hair loss benign prostatic hyperplasia bph also used treat excessive hair growth usually taken orally topical formulations patients hair loss designed minimize systemic exposure acting specifically hair finasteride inhibitor therefore works decreasing production dihydrotestosterone dht addition dht finasteride also inhibits production several anticonvulsant neurosteroids including allopregnanolone androstanediol adverse effects finasteride however men experience sexual dysfunction depression breast men sexual dysfunction may persist stopping may also hide early symptoms certain forms prostate finasteride patented approved medical use available generic commonly prescribed medication united states million finasteride used treatment symptomatic benign prostatic hyperplasia bph men enlarged treatment male pattern hair loss androgenetic alopecia physicians sometimes prescribe finasteride treatment benign prostatic hyperplasia bph informally known enlarged finasteride may improve symptoms associated bph difficulty urinating getting night urinate hesitation start end urination decreased urinary use drug showed significant sexual adverse effects erectile dysfunction less sexual desire particular obstructive symptoms due enlarged prostate finasteride also used treat male pattern baldness androgenic alopecia men condition develops caucasian men aged united states finasteride minoxidil two fda approved drugs treatment male pattern hair loss treatment finasteride slows hair provides improvement hair loss six months treatment effectiveness persisting long drug taking finasteride leads reduction scalp serum dht levels lowering scalp levels dht finasteride maintain increase amount terminal hairs anagen phase inhibiting sometimes reversing miniaturization hair follicle finasteride effective crown reduce hair loss areas finasteride also tested pattern hair loss women however results better finasteride less effective treatment scalp hair loss males aged years old finasteride decreases risk lowgrade prostate cancer may increase risk highgrade prostate cancer effect overall review found reduction risk prostate cancer followup study medicare claims participants prostate cancer prevention trial suggests reduction prostate cancer maintained even discontinuation however inhibitors found increase risk developing certain rare aggressive forms prostate cancer risk increase although studies observed impact inhibitor survival found people prostate finasteride found effective treatment hirsutism excessive facial andor body hair growth women study women hyperandrogenism due persistent adrenarche syndrome finasteride produced reduction facial hirsutism reduction bodily hirsutism years treatment studies using finasteride hirsutism also found clearly finasteride sometimes used hormone replacement therapy transgender women due antiandrogenic effects combination form estrogen however little clinical research finasteride use purpose conducted evidence safety efficacy moreover caution recommended prescribing finasteride transgender women finasteride may associated side effects depression anxiety suicidal ideation symptoms particularly prevalent transgender population others high risk cochrane review finasteride bph found men weighted mean age adverse effects rare nevertheless men taking finasteride increased risk impotence erectile dysfunction decreased libido ejaculation disorder versus fresh evidence suggested effects along disturbed neurosteroid production may persist finasteride use finasteride contraindicated food drug administration advises donation blood plasma deferred least one month taking last dose fda added warning inhibitors concerning increased risk highgrade prostate cancer treatment bph lowers psa prostatespecific antigen could mask development prostate although overall incidence male breast cancer clinical trials finasteride mg increased postmarketing reports breast cancer association use though available evidence provide clarity whether causative relationship finasteride metaanalysis found higher risk breast cancer men develop gynecomastia breast development enlargement following finasteride risk gynecomastia inhibitors low depressive symptoms suicidality use finasteride associated increased risk sexual dysfunction including erectile dysfunction decreased libido ejaculatory sexual adverse effects finasteride dutasteride linked lower quality life ability maintain intimate relationship cause stress adverse effect profiles finasteride somewhat different indications hair loss bph common adverse effects finasteride taken hair loss decrease sex drive erectile dysfunction decrease amount addition finasteride reported case reports cause sexual problems persist stopping update fda label noted reports decreased sex drive problems ejaculation difficulty achieving erection continued stopping medication update also referenced reports testicular pain male infertility andor poor quality common adverse sexual effects finasteride bph trouble getting keeping erection decrease sex drive decreased volume ejaculate ejaculation cochrane review found men taking finasteride bph mean age increased risk impotence erectile dysfunction decreased libido ejaculation disorder first year treatment rates became indistinguishable placebo years side effects usually got better finasteride may cause persistent adverse sexual neurological physical effects subset metastudy surveyed literature reversibility finasterides side effects identified three studies demonstrated full reversibility side effects eleven describe patients irreversible adverse events findings convincing retrospective review patients cohort developed persistent ed lasting longer days reports longterm postdiscontinuation adverse effects fraction former finasteride users led proposed postfinasteride syndrome validity questioned within medical individuals claiming experience pfs report sexual neurological hormonal psychological side effects persist extended period stopping reported symptoms include penile atrophy tissue changes decreased ejaculate volume quality reduced libido erectile dysfunction loss penile sensitivity decreased orgasm sensation dry skin metabolic changes muscle strength loss gynecomastia depression anxiety panic attacks insomnia anhedonia concentration problems memory impairment suicidal metaanalysis found significant association finasteride use postdiscontinuation depression suicidal ideation sexual dysfunction quality evidence status pfs legitimate distinct medical pathology remains subject debate editorial bmj called postfinasteride syndrome ill defined argued common features selfdiagnosed mystery syndromes morgellons multiple chemical sensitivity others including biomedical research community concluded based available evidence represents real serious known underlying biological mechanism proposed syndrome incidence lack clear diagnostic criteria variable reporting fraction different healthcare settings make problem challenging merck defendant approximately product liability lawsuits filed customers alleging experienced persistent sexual side effects following cessation treatment cases settled merck paid lump sum million usd distributed september cases remained outstanding united reuters reported faulty redactions court documents revealed allegations plaintiffs merck known persistent side effects original clinical trials chose disclose warning finasteride studied humans single doses mg continuous dosages mgday three months without adverse effects specific recommended antidote finasteride significant drug interactions observed finasteride limited selection finasteride specifically selective inhibitor type ii iii isoforms inhibiting two isozymes finasteride reduces formation potent androgen dihydrotestosterone dht precursor testosterone certain tissues body prostate gland skin hair finasteride type antiandrogen specifically androgen synthesis however authors define finasteride antiandrogen term refer specifically antagonists androgen finasteride results decrease circulating dht levels oral dosage mgday dht levels prostate gland oral dosage parallel circulating levels testosterone increase approximately local concentrations testosterone prostate gland increase local testosterone levels hair follicles increase around oral dosage finasteride mgday found achieve nearmaximal suppression dht levels mgday relative finasteride completely suppress dht production lacks significant inhibitory effects type isoenzyme less inhibitory potency type compared type ii halfmaximal inhibitory concentration nm nm contrast inhibitors three isoenzymes like dutasteride reduce dht levels entire body addition inhibiting finasteride also found competitively inhibit however affinity enzyme substantially less order magnitude less type hence unlikely clinical tissues different isozymes expressed fully different investigators obtained varying results different reagents methods tissues however different isozymes appear widely expressed notable tissues including prostate gland seminal vesicles testes epididymides skin hair follicles liver kidneys brain among inhibiting thus preventing dht production finasteride reduces androgen signaling tissues like prostate gland scalp prostate reduces prostate volume improves bph reduces risk prostate cancer finasteride reduces prostate volume men benign prostatic inhibition also reduces epididymal weight decreases motility normal morphology spermatozoa neurosteroids like derived dht allopregnanolone derived progesterone activate gabaa receptor brain finasteride prevents formation neurosteroids functions neurosteroidogenesis inhibitor may contribute reduction gabaa activity reduction gabaa receptor activation neurosteroids implicated depression anxiety sexual accordance finasteride potent inhibitor weak inhibitor medication decreases circulating levels steroids like allopregnanolone reduce concentrations steroids like pregnanolone acts potent gabaa receptor positive allosteric modulator similarly mean oral bioavailability finasteride approximately absorption finasteride affected steadystate mgday finasteride mean peak concentrations finasteride ngml conversely following single mg dose finasteride mean peak levels finasteride ngml nmoll plasma concentrations increased following weeks continued daily volume distribution finasteride plasma protein binding drug found cross barrier whereas levels semen found finasteride extensively metabolized liver first hydroxylation via aldehyde two major metabolites tertbutyl side chain monohydroxylated monocarboxylic acid metabolites show approximately inhibitory activity finasteride hence metabolites finasteride particularly drug terminal halflife hours adult men years age terminal halflife hours elderly men years eliminated metabolites feces finasteride also known synthetic androstane steroid analogue androgen steroid hormones like testosterone unconjugated steroid finasteride highly lipophilic james hamilton observed prepubertal castration prevents later development male pattern baldness mature julianne imperatomcginley cornell medical college new york attended conference birth defects reported group intersex children caribbean appeared sexually ambiguous birth initially raised girls grew external male genitalia masculine characteristic onset puberty children despite raised girls puberty generally heterosexual termed guevedoces local community means penis twelve research group found children shared genetic mutation causing deficiency enzyme male hormone dihydrotestosterone dht found etiology behind abnormalities male sexual development upon maturation individuals observed smaller prostates underdeveloped also observed lack incidence male pattern copies imperatomcginleys presentation seen p roy vagelos serving mercks basicresearch chief intrigued notion decreased levels dht led development smaller prostates dr vagelos sought create drug could mimic condition found children treat older men benign prostatic finasteride developed merck code name team led chemist gary rasmusson biologist jerry brooks developed potential inhibitors based transition state inhibitors using iterative process molecular design testing finasteride mg approved us food drug administration fda treatment bph merck marketed brand name proscar rasmusson brooks awarded ipos inventor year award work merck successful obtaining fda approval second indication finasteride mg treatment male pattern hair loss marketed brand name first inhibitor introduced followed dutasteride first study finasteride treatment hirsutism women published finasteride generic name drug inntooltip international nonproprietary name usantooltip united states adopted name bantooltip british approved name jantooltip japanese accepted name finastéride dcftooltip dénomination commune also known former developmental code names finasteride marketed primarily brand names propecia pattern hair loss proscar bph products merck mg finasteride propecia mg proscar mercks patent finasteride treatment bph expired june merck awarded separate patent use finasteride treat pattern hair loss expired november finasteride also marketed variety brand names throughout world antidoping agency banned finasteride discovered drug could used mask steroid removed list effective january improvements testing methods made ban athletes used finasteride banned international competition include skeleton racer zach lund bobsledder sebastien gattuso footballer romário ice hockey goaltender josé us food drug administration advises donation blood plasma deferred least one month taking last dose uk also onemonth deferral preliminary research suggests topical finasteride may effective treatment pattern hair topical finasteride like oral preparation reduces serum dht may involved cause acne inhibitors might effective treatment small retrospective study reported finasteride effective treatment acne women normal testosterone randomized controlled trial found finasteride less effective flutamide ethinylestradiolcyproterone acetate birth control pill treatment acne women high androgen androgens estrogens may involved cause hidradenitis suppurativa acne two case series reported finasteride effective treatment hidradenitis suppurativa girls finasteride antiandrogens might useful treatment disorder research httpsenwikipediaorgwikifinasteride